The relationship between bone metastasis from human breast cancer and integrin αvβ3 expression

Anticancer Research

Volumn 25, Issue 1 A, 2005, Pages 79-83

  Takayama, Shin ^a   Ishii, Seiichiro ^b   Ikeda, Tadashi ^a   Masamura, Shigeru ^a   Doi, Masakazu ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Bone metastasis; Breast cancer; Integrins; Osteoclast activation; Osteoclasts

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BETA3 INTEGRIN; CD51 ANTIGEN; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; VERY LATE ACTIVATION ANTIGEN 2; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 16344380043     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ota I and Matsuura S: Adhesion molecules and cancer metastasis. Rinsho Byori 45(6): 528-533, 1997.
2. Helen L, Alphan F and Kitazawa S: Integrin alpha v beta 3 expression by bone-residing breast cancer metastases. Diagn Mol Pathol 5(2): 127-135, 1996.
3. Rachel JT, Theresa AG and Juan JY: Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140(10): 4451-4458, 1999.
4. Deryugina EI, Bourdon MA and Jungwirth K: Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer 86(1): 15-23, 1999.
5. Singh B, Fu C and Bhattacharya J: Vascular expression of the alpha(v)beta(3)-integrin in lung and other organs. Am J Physiol Lung Cell Mol Physiol 278(1): L217-L226, 2000.
6. Illera MJ, Cullinan E and Gui Y: Blockade of the alpha(v) beta(3) integrin adversely affects implantation in the mouse. Biol Reprod 62(5): 1285-1290, 2000.
7. Tamura H, Ishii S and Ikeda T: Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. Surg Oncol 5(3): 141-147, 1996.
8. Wada N, Ishii S and Ikeda T: Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Anticancer Res 19(5C): 4515-4521, 1999.
9. Stephen C, Wah-Tung H and Gwilym J: The integrin specificity of human recombinant osteopontin. Biochemical Pharmacol 58: 1567-1578, 1999.
10. Faccio R, Grano M and Colucci S: Activation of alpha v beta 3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin. Biochem Biophys Res Commun 249(2): 522-525, 1998.
11. Hartman GD and Duggan ME: Alpha(v) beta(3) Integrin antagonists as inhibitors of bone resorption. Expert Opin Investig Drugs 9(6): 1281-1291, 2000.
12. Meyer T, Marshall JF and Hart IR: Expression of alpha v integrins and vitronectin receptor identity in breast cancer cells. Br J Cancer 77(4): 530-536, 1998.
13. Oda K, Itoh H and Utsunomiya H: Bio-histochemical aspects of integrins (alpha 2 beta 1, alpha 6 beta 1) in invasive mammary carcinomas: an immunohistochemical study. Pathol Int 44(6): 435-441, 1994.
14. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573, 1898.
15. Shinar D. M, Schmidt A and Halperin D: Expression of alpha v beta 3 integrin subunits in rat osteoclasts in situ. Bone Min Res 8(4): 403-414, 1993.
16. 3 for prevention of bone metastasis (BM) of human breast cancer. J Bone Min Metabol 19 Supplement: 36(Proc.), 2001.